CIK 0001724521 · Large accelerated filer
Arcus Biosciences, Inc.
Sign in to watch- Ticker
- RCUS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473898435
- Phone
- (510) 694-6200
- Business address
- 3928 POINT EDEN WAY, HAYWARD, CA, 94545
- 4 Shares withheld for taxes General Counsel gave up 4,182 shares (to pay taxes)
- 4 Grant or award Director acquired 8,400 shares (grant or award)
- 4 Grant or award Director acquired 8,400 shares (grant or award)
- 4 Grant or award Director acquired 8,400 shares (grant or award)
- 4 Grant or award Director acquired 8,400 shares (grant or award)
- 4 Grant or award Director acquired 8,400 shares (grant or award)
- 4 Grant or award Director acquired 8,400 shares (grant or award)
- 4 Grant or award Director acquired 8,400 shares (grant or award)
- 4 Planned sale Chief Operating Officer sold 11,551 shares at $17.55 ($202,720)
- 4 Planned sale Chief Operating Officer sold 13,449 shares at an average $17.92 ($240,941)
- 4 Planned sale Chief Operating Officer sold 58,625 shares at an average $20.09 ($1,177,967)
- 4 Planned sale President sold 27,032 shares at an average $20.09 ($543,187)
- 4/A Grant or award Chief Financial Officer acquired 22,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 15,238,095 shares at $21.00 ($319,999,995)
- 4 Grant or award Chief Financial Officer acquired 21,300 shares (grant or award)
- 4 Grant or award President acquired 40,000 shares (grant or award)
- 4 Grant or award Chief Accounting Officer acquired 8,850 shares (grant or award)
- 4 Grant or award General Counsel acquired 26,700 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 100,000 shares (grant or award)
Page 5 of 15 · 290 filings